The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT01608724 · COMPLETED

Trial details

NCT number: NCT01608724
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Non-Insulin-Dependent

Start date: 2012-11-01
Primary completion: 2014-05-01
Enrollment: 2165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.